SCHEMBL10275559

SCHEMBL10275559

COc1ccc(-n2cc3c(-c4ccc(F)cc4F)c(C)[nH]n3c2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PMM2 O15305 2/20 0.38
MIF P14174 2/20 0.38
MPI P34949 2/20 0.38
PHOSPHO1 Q8TCT1 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
TP53 P04637 1/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
RECQL P46063 1/20 0.37
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
ATM Q13315 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10275560 0.65 PDE4A (0.47) PMM2MIFMPIPHOSPHO1NPC1
SCHEMBL6068558 0.64 CYP2C19 (0.55) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL13152153 0.63 PMM2 (0.46) PMM2MIFMPIPHOSPHO1NPC1
SCHEMBL10275232 0.61 PMM2 (0.37) PMM2MIFMPIPHOSPHO1NPC1
SCHEMBL27093095 0.61 MAPK14 (0.38) MAPTGAAL3MBTL1
SCHEMBL2710033 0.61 APP (0.40) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL2726616 0.61 ACHE (0.47) ALDH1A1MAPTLMNAHTTKDM4E
SCHEMBL10275360 0.61 AR (0.40) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL10276472 0.61 PMM2 (0.39) PMM2MIFMPIPHOSPHO1NPC1
SCHEMBL28854556 0.61 ALDH1A1 (0.46) PMM2MIFMPIPHOSPHO1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 PMM2 1860/4885MIF 4872/4885MPI 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.